Tel：0755-86350988
E-mail：sales@jymedtech.com
R&D and Innovation

R&d and Innovation


R&D fields
The R&D field of JYMed is innovative drugs and generic drugs based on synthetic peptide drugs, including the whole process of research from project approval, evaluation screening, process research design and development, quality research, preclinical pharmacy evaluation to clinical reporting. 
The main products include ：
Have drug substance, drug product, cosmetic peptide, veterinary peptide, custom peptide and et al, the curative effect of which involve medical field, cosmetic field and veterinary drug field. The medical field include diabetes, digestive system, gynecology, immune system, cardiovascular, tumor, central nervous system, respiratory system, gastrointestinal system, bacterial or fungal infection, et al. The cosmetic field include wrinkle removing, anti-aging, freckle removing, eyelash growth promoting, et al. The veterinary drug field include the treatment of gut bacteria, parasite, infectious diseases, digestive diseases, urinary infection, respiratory diseases and reproductive system diseases, et al.

JYMed is committed to the research and development of new polypeptide production technologies and new application technologies, which has core technologies for the industrialization of polypeptide drugs. It successfully achieves the mass production of ultra-high quality peptide drugs such as long peptides and modified peptides, drastically reduces production costs and environmental safety costs. It provides necessary technical support for the development of domestic peptide industrialization. With its high quality product and opening CRO service, 


JYMed’s market network covers both domestic and overseas market. The cooperative customers mainly focus on large-scale new drug R&D companies. In recent years, the company consistently focus on the development and production of peptide drugs, actively carry out business development and Industrial distribution, and also insist on increasing investment in high-end chemical and biological drugs, in order to strive for long-term operation, comprehensive development, and form a more prominent competitive advantage.